Hamdard Labs enters OTX segment, launches 13 new products

Published On 2021-12-23 08:53 GMT   |   Update On 2021-12-23 08:53 GMT

New Delhi: Health and wellness firm Hamdard Laboratories on Monday said it has expanded its product portfolio with the introduction of 13 new products in the OTX (nutraceuticals) and Unani medicine segments.

The new OTX range consists of Onion Oil, Kalonji Oil, Ashokarishta, Nozeem, Liquirub, Isabgol++, which are beneficial for skin, hair, body ache, constipation, nose and chest congestion, etc., the company said in a statement.

"Holistic wellness and self-care are among the top priorities of consumers. With many challenges such as restricted movement and worsening pollution facing us today, we recognize the need to make high-quality Unani products easily available to promote holistic health and wellness," Hamdard Laboratories (Medicine Division) Chairman Abdul Majeed said in a statement.

The company's products are formulated with the best ingredients and offer the goodness of nature with no side effects, the key factors influencing millennials' purchase decisions, he added.

The products are readily available across Hamdard Wellness Centres, chemist shops and e-commerce sites, including 1 mg, Amazon and Healthmug, the company stated.

Read also: Hamdard Labs unveils 12 OTC immunity-boosting medicines

Hamdard Labs (India) is a Unani pharmaceutical company in India. The company was  established by Late Hakeem Abdul Hameed Sahib in 1906.

Read also: Covid-19: Hamdard Labs to begin clinical trials of immunity-boosting drugs Infuza, Kulzam

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News